Literature DB >> 23635409

Alterations in the nuclear architecture produced by the overexpression of tau protein in neuroblastoma cells.

Hugo C Monroy-Ramírez1, Gustavo Basurto-Islas, Raul Mena, Bulmaro Cisneros, Lester I Binder, Jesús Avila, Francisco Garcia-Sierra.   

Abstract

Abnormal intracellular aggregation of tau protein is a pathological condition leading to neuronal death in Alzheimer's disease. Fibrillar and nonfibrillar aggregates of tau protein alter the normal functioning of neurons by disturbing important cellular processes and distinct membranous organelles. However, tau-caused alterations in the nuclear compartment are not totally established so far. In our study we evaluated whether tau protein and its Asp421-truncated variant produce alterations in the normal architecture of the nucleus when expressed in cultured neuroblastoma cells. After 48 hours of transfection, significant deformity of the nuclear compartment with extensive lobulations along the nuclear envelope was observed in SH-SY5Y cells expressing either full-length tau or Asp421-truncated tau. This aberrant formation did not involve either nuclear fragmentation or cell death. The lobulated nuclei were devoid of tau protein, which mostly remained in the cytoplasm in a nonfibrillar state. Degradation of nuclear Lamins was not observed in tau-expressing SH-SY5Y cells, and a cell-cycle analysis did not show aberrant chromosome accumulation. Thus multiple division defects leading to multinucleation were discarded. The lobulated nuclei in tau-expressing SH-SY5Y cells seem to more resemble the multilobular phenotype of the nuclear envelope seen in Lamin-mutated cells from those pathological conditions leading to premature aging. Nevertheless, in our tau-expressing cells, the abnormal formation of cortical and perinuclear rings of tubulin generated by tau binding may be a more feasible mechanism of a nuclear-cytoskeleton generating force that causes the nuclear deformation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23635409     DOI: 10.3233/JAD-122401

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  8 in total

1.  MAPT (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastoma.

Authors:  Saif Zaman; Boris I Chobrutskiy; George Blanck
Journal:  Cell Cycle       Date:  2018-11-18       Impact factor: 4.534

2.  Novel marker for the onset of frontotemporal dementia: early increase in activity-dependent neuroprotective protein (ADNP) in the face of Tau mutation.

Authors:  Yulie Schirer; Anna Malishkevich; Yotam Ophir; Jada Lewis; Eliezer Giladi; Illana Gozes
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

3.  Profiling murine tau with 0N, 1N and 2N isoform-specific antibodies in brain and peripheral organs reveals distinct subcellular localization, with the 1N isoform being enriched in the nucleus.

Authors:  Chang Liu; Jürgen Götz
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

Review 4.  Alzheimer's disease: An acquired neurodegenerative laminopathy.

Authors:  Bess Frost
Journal:  Nucleus       Date:  2016-05-11       Impact factor: 4.197

5.  Halting of Caspase Activity Protects Tau from MC1-Conformational Change and Aggregation.

Authors:  Emma Mead; Dimitra Kestoras; Yolanda Gibson; Lucy Hamilton; Ross Goodson; Sophie Jones; Sarah Eversden; Peter Davies; Michael O'Neill; Michael Hutton; Philip Szekeres; Joanna Wolak
Journal:  J Alzheimers Dis       Date:  2016-10-18       Impact factor: 4.472

6.  Inhibitory effects of carvacrol on the expression of secreted aspartyl proteinases 1-3 in fluconazole-resistant Candida albicans isolates.

Authors:  Seyedeh Sedigheh Hosseini; Mohammad Hossein Yadegari; Masoumeh Rajabibazl; Ezzat Allah Ghaemi
Journal:  Iran J Microbiol       Date:  2016-12

7.  Tau Modulates mRNA Transcription, Alternative Polyadenylation Profiles of hnRNPs, Chromatin Remodeling and Spliceosome Complexes.

Authors:  Mauro Montalbano; Elizabeth Jaworski; Stephanie Garcia; Anna Ellsworth; Salome McAllen; Andrew Routh; Rakez Kayed
Journal:  Front Mol Neurosci       Date:  2021-12-03       Impact factor: 5.639

Review 8.  Regulating Phase Transition in Neurodegenerative Diseases by Nuclear Import Receptors.

Authors:  Amandeep Girdhar; Lin Guo
Journal:  Biology (Basel)       Date:  2022-07-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.